Co-targeting of PD-1 with either CD160 or HVEM showed very low levels of enhancement when peptide pools specific to other infectious agents (CEFT: CMV, EBV, Influenza and Tetanus) were used as controls (Additional file 3A & B). Here, CD160 is linked to tetanus.